Correlation Between Alexandria Real and TNF Pharmaceuticals,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alexandria Real and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alexandria Real and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alexandria Real Estate and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Alexandria Real and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alexandria Real with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alexandria Real and TNF Pharmaceuticals,.

Diversification Opportunities for Alexandria Real and TNF Pharmaceuticals,

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Alexandria and TNF is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Alexandria Real Estate and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Alexandria Real is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alexandria Real Estate are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Alexandria Real i.e., Alexandria Real and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Alexandria Real and TNF Pharmaceuticals,

Considering the 90-day investment horizon Alexandria Real Estate is expected to generate 0.21 times more return on investment than TNF Pharmaceuticals,. However, Alexandria Real Estate is 4.69 times less risky than TNF Pharmaceuticals,. It trades about -0.17 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about -0.1 per unit of risk. If you would invest  11,219  in Alexandria Real Estate on November 7, 2024 and sell it today you would lose (1,772) from holding Alexandria Real Estate or give up 15.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Alexandria Real Estate  vs.  TNF Pharmaceuticals,

 Performance 
       Timeline  
Alexandria Real Estate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alexandria Real Estate has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
TNF Pharmaceuticals, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TNF Pharmaceuticals, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Alexandria Real and TNF Pharmaceuticals, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alexandria Real and TNF Pharmaceuticals,

The main advantage of trading using opposite Alexandria Real and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alexandria Real position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.
The idea behind Alexandria Real Estate and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets